Navitoclax (ABT-263) [CAS: 923564-51-6]
Catalog-Number:
S1001
Storage
-20°C
Description
Navitoclax Research Compound: Pioneering the Future of Cancer Research
Overview: Navitoclax, a potent and selective BCL-2 family inhibitor, is at the forefront of cancer research and therapy. This small-molecule compound is designed for use in various scientific studies, particularly those exploring the pathways of apoptosis and cancer cell survival.
Key Features:
- Targeted Action: Navitoclax specifically targets key proteins in the BCL-2 family, making it a powerful tool for studying apoptosis in cancer cells.
- Research-Grade Quality: Our Navitoclax is synthesized to the highest purity standards, ensuring reliable and consistent results in your experiments.
- Versatile Application: Widely used in oncology research, including studies on lymphomas, leukemias, and solid tumors.
- Available in Various Quantities: To accommodate different scales of research, we offer Navitoclax in multiple quantity options.
- Enhanced Research Accuracy: High purity and selectivity of Navitoclax provide precise insights into apoptosis mechanisms and cancer biology.
- Innovative Cancer Research: Contributes to groundbreaking discoveries in cancer treatment and therapy development.
- Comprehensive Data Sheet: Each purchase includes a detailed data sheet with storage instructions, molecular structure, and safety information.
- For Research Use Only: Not for human or veterinary use.
- Handling Precautions: Requires careful handling and storage as per the provided guidelines.
- Cancer Research Laboratories
- Molecular Biology and Biochemistry Studies
- Pharmaceutical Development and Screening
- Academic and Clinical Research Institutions
| CAS No.: | 923564-51-6 |
|---|---|
| Storage: | -20°C |
| Target: | Bcl-2, Bcl-w, Bcl-xL |